Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GOT2 pseudogene 5 (GOT2P5) is a non-functional genomic locus related by sequence to the glutamic-oxaloacetic transaminase 2 gene. Unlike functional protein-coding genes, pseudogenes typically lack protein output due to disabling mutations. GOT2P5 does not encode a functional enzyme and has no confirmed role in cellular biology or disease. Distinction must be made from the active mitochondrial enzyme GOT2, which participates in cellular redox balance and is implicated in cancer metabolism. The confusion often arises in literature and databases that group pseudogenes with their functional counterparts, but available evidence does not support a role for GOT2P5 in biology, disease, or as a drug target[3][4].
None. No mechanisms of action relevant to drugs, as this pseudogene does not encode a functional target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamic-oxaloacetic transaminase 2 pseudogene 5 (GOT2P5).